Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherapy

NCT01079780 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

136

Enrollment

NETWORK

Sponsor class

Conditions

Colorectal Cancer

Interventions

BIOLOGICAL: cetuximab
BIOLOGICAL: ramucirumab
DRUG: irinotecan hydrochloride

Sponsor

Eastern Cooperative Oncology Group

Collaborators

[object Object]